Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181576 | 0.92 | ALDH1A1 (0.47) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Acrylic Acid SCHEMBL31138121 | 0.88 | ALDH1A1 (0.43) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13658812 | 0.84 | ALDH1A1 (0.40) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL1851416 | 0.79 | ALDH1A1 (0.47) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL20074481 | 0.79 | ALDH1A1 (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL12862497 | 0.79 | ALDH1A1 (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL20183953 | 0.78 | ALDH1A1 (0.46) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL22524772 | 0.77 | ALDH1A1 (0.42) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL21861375 | 0.76 | TSHR (0.44) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL4096630 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147369-A1 | ACRYLATED UVA AND METHOD OF MAKING THE SAME | MADICO, INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147369-A1 | ACRYLATED UVA AND METHOD OF MAKING THE SAME | UNG, UMPS, UGT1A7 | ALDH1A1 22/4885TP53 1295/4885HIF1A 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.